JPRN-UMIN000021583Recruiting未知
Evaluation of the effect of rosuvastatin on renoprotective effect - Rosuvastatin-kidney study
Rosuvastatin-kidney study group0 sites40 target enrollmentStarted: March 25, 2016Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patient is started or changed renin angiotensin system inhibitor.
Investigators
Similar Trials
Completed
Phase 3
The assessment of effect of Rosuvastatin use in venous thromboembolismVenous thromboembolism includes deep vein thrombosis and pulmonary embolism.venous embolism and thrombosisCode I82IRCT20210416050990N1Shahid Beheshti University of Medical Sciences220
Recruiting
Phase 3
A clinical trial to investigate the efficiency of rosuvastatin in acute cardiomyopathy induced anthracyclineCardiomyopathyIRCT2016121213090N3Vice chancellor for research of Mazandaran University of Medical Sciences80
Completed
Phase 3
Evaluation of the effects of Rosuvastatin in the treatment of patients with deep vein thrombosis(DVT)IRCT20150621022852N4Shahid Beheshti University of Medical Sciences50
Recruiting
Phase 2
Rosuvastatin in patients with moderate brain traumaModerate traumatic brain injury.Diffuse traumatic brain injuryS06.2IRCT20230627058603N2Esfahan University of Medical Sciences200
Recruiting
Not Applicable
Comparison between the effect of Rosuvastatin and Orlept (Sodium Valproate) in Decrease of migraine headachesMigraine headaches.MigraineIRCT20180114038369N1Ghoum University of Medical Sciences40